Publication: Cost Effectiveness of Siponimod for Secondary Progressive Multiple Sclerosis in Turkey
| dc.authorwosid | Yılmaz, Canan/Agu-8778-2022 | |
| dc.contributor.author | Tatar, M. | |
| dc.contributor.author | Osbalas, T. | |
| dc.contributor.author | Saracoglu, B. | |
| dc.contributor.author | Olmez, C. | |
| dc.contributor.author | Yarci, B. | |
| dc.contributor.author | Akdernir, A. C. | |
| dc.contributor.author | Sen, S. | |
| dc.date.accessioned | 2025-12-11T00:41:56Z | |
| dc.date.issued | 2022 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Tatar, M.] Polar Hlth Econ & Policy Consultancy, Ankara, Turkey; [Osbalas, T.; Saracoglu, B.; Olmez, C.; Yarci, B.; Akdernir, A. C.; Yilmaz, C.] Novartis, Istanbul, Turkey; [Sen, S.] Ondokuz Mayis Univ, Samsun, Turkey | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded - Social Science Citation Index | |
| dc.identifier.endpage | S184 | en_US |
| dc.identifier.issn | 1098-3015 | |
| dc.identifier.issn | 1524-4733 | |
| dc.identifier.issue | 12 | en_US |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | S184 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/38537 | |
| dc.identifier.volume | 25 | en_US |
| dc.identifier.wos | WOS:000897594901243 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science Inc | en_US |
| dc.relation.ispartof | Value in Health | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Cost Effectiveness of Siponimod for Secondary Progressive Multiple Sclerosis in Turkey | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
